Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Horacio J. Asbun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7713-1805; OpenAlex author ID A5078989718, A5081205674. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
95
Papers, trials and grants by year

2013: 2 papers · 2014: 4 papers · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 17

  1. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. Co-author DOI 10.1007/s13304-024-01860-0↗
  2. Laparoscopic distal pancreatectomy for pancreatic cancer: an overview of evaluation and treatment strategies. Last author DOI 10.21037/jgo-23-784↗
  3. Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic R… Co-author DOI 10.1177/10732748221150228↗
  4. Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarcinoma: a multi-institutional analysis. Co-author DOI 10.1016/j.hpb.2019.12.012↗
  5. Minimally Invasive Approaches to Pancreatic Cancer. Last author DOI 10.1016/j.soc.2018.11.006↗
  6. Pancreatic Adenocarcinoma, Version 1.2019. Co-author DOI 10.6004/jnccn.2019.0014↗
  7. Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study. Co-author DOI 10.1089/pancan.2018.0011↗
  8. Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution. Last author DOI 10.1007/s00464-016-5222-1↗
  9. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2017.0131↗
  10. Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Adenocarcinoma. Last author DOI 10.1007/s00268-016-3412-6↗
  11. Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature. First author DOI 10.1016/j.dld.2015.06.015↗
  12. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Co-author DOI 10.1016/j.surg.2014.02.001↗
  13. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Co-author DOI 10.1016/j.surg.2014.02.009↗
  14. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic … Co-author DOI 10.1016/j.surg.2014.06.016↗
  15. ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens. Co-author DOI 10.2174/1566524013666131217112921↗
  16. Minimally invasive surgical techniques for pancreatic cancer: ready for prime time? Last author DOI 10.1007/s00534-013-0614-2↗
  17. Risk of gastric or peritoneal recurrence, and long-term outcomes, following pancreatic cancer resection with preoperative endosonographically guided fine needl… Co-author DOI 10.1055/s-0033-1344216↗

Closest collaborators

The 25 strongest of 95 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Andrew Stauffer · 9 shared papers, 2013–2024 · strength 0.95
  2. Domenech Asbun · 1 shared paper, 2024 · strength 0.36
  3. Mokenge Peter Malafa · 3 shared papers, 2017–2023 · strength 0.25
  4. Kabir Mody · 3 shared papers, 2016–2018 · strength 0.24
  5. Massimo Raimondo · 4 shared papers, 2013–2018 · strength 0.23
  6. Alessandro Coppola · 2 shared papers, 2016–2017 · strength 0.16
  7. Michael B. Wallace · 3 shared papers, 2013–2018 · strength 0.15
  8. Michael David Chuong · 1 shared paper, 2023 · strength 0.14
  9. John Michael Bryant · 1 shared paper, 2023 · strength 0.14
  10. Russell F. Palm · 1 shared paper, 2023 · strength 0.14
  11. Jessica M. Frakes · 1 shared paper, 2023 · strength 0.14
  12. Jason W. Denbo · 1 shared paper, 2023 · strength 0.14
  13. Adeel Kaiser · 1 shared paper, 2023 · strength 0.14
  14. Dae Won Kim · 1 shared paper, 2023 · strength 0.14
  15. Sarah E. Hoffe · 1 shared paper, 2023 · strength 0.14
  16. Jason B. Fleming · 1 shared paper, 2023 · strength 0.14
  17. Pamela Joy Hodul · 1 shared paper, 2023 · strength 0.14
  18. Joseph R. Broucek · 1 shared paper, 2019 · strength 0.14
  19. Dominic E. Sanford · 1 shared paper, 2019 · strength 0.14
  20. William G. Hawkins · 2 shared papers, 2017–2019 · strength 0.11
  21. Andrew H. Ko · 2 shared papers, 2017–2019 · strength 0.11
  22. Brian G. Czito · 2 shared papers, 2017–2019 · strength 0.11
  23. Charles H. Cha · 2 shared papers, 2017–2019 · strength 0.11
  24. Mahmoud M. Al-Hawary · 2 shared papers, 2017–2019 · strength 0.11
  25. Noelle K. LoConte · 2 shared papers, 2017–2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.